Literature DB >> 21108696

Rectal hyposensitivity is uncommon and unlikely to be the central cause of obstructed defecation in patients with high-grade internal rectal prolapse.

N A Wijffels1, G Angelucci, A Ashrafi, O M Jones, C Cunningham, I Lindsey.   

Abstract

BACKGROUND: There are several causes of obstructed defecation one of which is thought to be internal rectal prolapse. Operations directed at internal prolapse, such as laparoscopic ventral rectopexy, may improve obstructed defecation symptoms significantly. It is not clear whether the obstructed defecation with internal prolapse is a mechanical phenomenon or whether it results changes in rectal sensitivity. This study aimed to evaluate rectal sensory function in patients with obstructed defecation and high-grade internal rectal prolapse.
METHODS: This study represents a retrospective review of a prospectively collected database of patients attending a tertiary referral pelvic floor unit. Patients with high-grade (recto-anal) intussusception formed the basis of this study. Rectal sensory function was determined by intrarectal balloon inflation. Three parameters (sensory threshold, urge to defecate and maximum tolerated volumes) were recorded. Abnormal sensitivity was defined as partial (one or two parameters abnormal) or total (all three abnormal). KEY
RESULTS: Four hundred and eight patients with high-grade internal rectal prolapse both with and without obstructed defecation symptoms were studied. Two hundred and forty one (59%) had normal sensation. Eighteen (4%) had total hyposensitivity and three (1%) total hypersensitivity. A further 96 (24%) had partial hyposensitivity whilst 50 (12%) had partial hypersensitivity. Neither hypersensitivity nor hyposensitivity differed between patients with and without symptoms of obstructed defecation. CONCLUSIONS & INFERENCES: Rectal hyposensitivity is relatively uncommon in patients with high-grade internal rectal prolapse and obstructed defecation. Internal rectal prolapse may cause obstructed defecation through a mechanical process. It does not appear that rectal hyposensitivity plays a significant part in the pathological process.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21108696     DOI: 10.1111/j.1365-2982.2010.01625.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

1.  Laparoscopic ventral rectopexy in patients with fecal incontinence associated with rectoanal intussusception: prospective evaluation of clinical, physiological and morphological changes.

Authors:  A Tsunoda; T Takahashi; K Hayashi; Y Yagi; H Kusanagi
Journal:  Tech Coloproctol       Date:  2018-06-28       Impact factor: 3.781

2.  Rectal hyposensitivity and functional anorectal outlet obstruction are common entities in patients with functional constipation but are not significantly associated.

Authors:  Tae Hee Lee; Joon Seong Lee; Su Jin Hong; Seong Ran Jeon; Soon Ha Kwon; Wan Jung Kim; Hyun Gun Kim; Won Young Cho; Joo Young Cho; Jin-Oh Kim; Ji Sung Lee
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

3.  Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy.

Authors:  Robin Krol; Robert Jan Smeenk; Emile N J T van Lin; Wim P M Hopman
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

4.  Rectal Hyposensitivity Is Associated With a Defecatory Disorder But Not Delayed Colon Transit Time in a Functional Constipation Population.

Authors:  Ting Yu; Dong Qian; Yongping Zheng; Ya Jiang; Ping Wu; Lin Lin
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  Rectal hyposensitivity.

Authors:  Rebecca E Burgell; S Mark Scott
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

6.  Normal Rectal Filling Sensations in Patients with an Enlarged Rectum.

Authors:  Sanne J Verkuijl; Monika Trzpis; Paul M A Broens
Journal:  Dig Dis Sci       Date:  2018-07-12       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.